Diabetes, Digestive, and Kidney Diseases Extramural Research in Alabama
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $132 million to recipients in Alabama in 126 grants from fiscal 2021 to 2025, 1.4% of the program's national total. University of Alabama at Birmingham received the most, $119 million.
- Awarded in Alabama$132 million
- Awards126
- Share of the program1.4%
- Rank among states21st of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 79 | $27.6 million |
| FY 2022 | 72 | $25.4 million |
| FY 2023 | 71 | $26.3 million |
| FY 2024 | 65 | $26.0 million |
| FY 2025 | 55 | $26.5 million |
Recipients in Alabama
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Alabama at Birmingham | Colleges and universities | 117 | $119 million |
| University of Alabama | Colleges and universities | 4 | $5.6 million |
| Reliant Glycosciences LLC | Small businesses | 2 | $3.2 million |
| Endomimetics, Inc. | Small businesses | 1 | $1.9 million |
| Tuskegee University | Colleges and universities | 1 | $1.5 million |
| Auburn University | Colleges and universities | 1 | $836,340 |
Open opportunities under this program
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
See all 68 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Alabama?
$132 million from fiscal 2021 to 2025, across 126 awards. Alabama ranks 21st of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Alabama?
The largest recipient is University of Alabama at Birmingham, with $119 million in 117 awards. Next are University of Alabama and Reliant Glycosciences LLC.
Can organizations in Alabama apply now?
Yes, 68 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Alabama
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Special Education Grants to States
- Head Start